Compare RMD & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | DRI |
|---|---|---|
| Founded | 1989 | 1968 |
| Country | United States | United States |
| Employees | 10600 | N/A |
| Industry | Medical/Dental Instruments | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4B | 22.2B |
| IPO Year | N/A | 2000 |
| Metric | RMD | DRI |
|---|---|---|
| Price | $207.25 | $203.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 25 |
| Target Price | ★ $292.56 | $226.50 |
| AVG Volume (30 Days) | ★ 1.3M | 878.8K |
| Earning Date | 04-30-2026 | 03-19-2026 |
| Dividend Yield | 1.13% | ★ 3.06% |
| EPS Growth | N/A | ★ 4.11 |
| EPS | N/A | ★ 6.87 |
| Revenue | N/A | ★ $12,076,700,000.00 |
| Revenue This Year | $10.60 | $10.58 |
| Revenue Next Year | $7.41 | $3.73 |
| P/E Ratio | ★ $25.61 | $28.77 |
| Revenue Growth | N/A | ★ 6.03 |
| 52 Week Low | $198.61 | $169.00 |
| 52 Week High | $293.81 | $228.27 |
| Indicator | RMD | DRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 58.47 |
| Support Level | $198.63 | $202.38 |
| Resistance Level | $260.21 | $203.71 |
| Average True Range (ATR) | 4.85 | 5.31 |
| MACD | 1.26 | 0.66 |
| Stochastic Oscillator | 62.06 | 89.36 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.